MTOR and cancer: Moreover, the pathway activity analysis suggested that TMEM59L was significantly involved in 10 salient cancer-related pathways, namely DNA damage response, apoptosis, RTK, cell cycle, Hormone AR, Hormone ER, TSC–mTOR, Ras/MAPK, EMT and PI3K/AKT signaling pathways (Figure 4B).